Naval Parikh, MD, is a respected presence in the South Florida medical sphere who facilitates clinical trials at NAPA Research. Possessing a background in emergency medicine, Naval Parikh, MD, stays current on developments in the broader health care field.
A recent UConn Health study published in the Proceedings of the National Academy of Sciences brought focus to findings on the premature aging of brain stem cells among people living with the most severe types of multiple sclerosis (MS).
As MS advances it impacts the ability of nerves to transmit consistent signals throughout the body, which results in challenges in completing basic tasks such as holding a pen or walking. The major issue is degenerated and inflamed myelin, which acts as insulation around the nerves. The good news is that long periods of remission often occur among those with MS, which allows ample opportunity for recovery.
The periods of relative wellness would be an optimal time for targeted therapeutics focused on prematurely old brain stem cells among progressive MS patients, which act differently than normal brain cells. Understanding them provides important pathways for new treatments that address the underlying neurological deterioration involved in MS.
No comments:
Post a Comment